Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126628221 | 12662822 | 1 | I | 20160808 | 20160818 | 20160818 | EXP | US-PFIZER INC-2016381341 | PFIZER | 76.00 | YR | M | Y | 0.00000 | 20160818 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126628221 | 12662822 | 1 | PS | CYTARABINE. | CYTARABINE | 1 | 20 MG/M2, 2X/DAY | Y | 72168 | 20 | MG/M**2 | SOLUTION FOR INJECTION | BID | ||||||
| 126628221 | 12662822 | 2 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 100 MG, DAILY | 0 | 100 | MG | TABLET | |||||||
| 126628221 | 12662822 | 3 | C | AMIODARONE HCL | AMIODARONE HYDROCHLORIDE | 1 | Oral | 200 MG, DAILY | 0 | 200 | MG | TABLET | |||||||
| 126628221 | 12662822 | 4 | C | AMIODARONE HCL | AMIODARONE HYDROCHLORIDE | 1 | Oral | 400 MG, 2X/DAY | 0 | 400 | MG | TABLET | BID | ||||||
| 126628221 | 12662822 | 5 | C | AVODART | DUTASTERIDE | 1 | Oral | 0.5 MG, DAILY | 0 | .5 | MG | CAPSULE | |||||||
| 126628221 | 12662822 | 6 | C | CLOTRIMAZOLE. | CLOTRIMAZOLE | 1 | Oral | 10 MG, 3X/DAY | 0 | 10 | MG | TABLET | TID | ||||||
| 126628221 | 12662822 | 7 | C | CYCLOBENZAPRINE HCL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | Oral | 5 MG, DAILY (ONCE DAILY AT BEDTIME) | 0 | 5 | MG | TABLET | |||||||
| 126628221 | 12662822 | 8 | C | LUNESTA | ESZOPICLONE | 1 | Oral | 3 MG, UNK(TAKE BY MOUTH NIGHTLY) | 0 | 3 | MG | TABLET | QD | ||||||
| 126628221 | 12662822 | 9 | C | TRICOR | FENOFIBRATE | 1 | 145 MG, DAILY | 0 | 145 | MG | TABLET | ||||||||
| 126628221 | 12662822 | 10 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | 50 MCG/ACT SUSPENSION | 0 | 50 | UG | |||||||||
| 126628221 | 12662822 | 11 | C | LASIX | FUROSEMIDE | 1 | Oral | 20 MG, 2X/DAY | 0 | 20 | MG | TABLET | BID | ||||||
| 126628221 | 12662822 | 12 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | Topical | UNK, 2X/DAY (2.5 % CREAM; SIG: APPLY TOPICALLY 2 TIMES DAILY) | 0 | CREAM | BID | ||||||||
| 126628221 | 12662822 | 13 | C | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | 500 MG, UNK | 0 | 500 | MG | TABLET | ||||||||
| 126628221 | 12662822 | 14 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | 5 MG, UNK | 0 | 5 | MG | |||||||||
| 126628221 | 12662822 | 15 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | Oral | 25 MG, 2X/DAY | 0 | 25 | MG | TABLET | BID | ||||||
| 126628221 | 12662822 | 16 | C | SALONPAS PAIN RELIEF | MENTHOLMETHYL SALICYLATE | 1 | Topical | UNK (MENTHOL 10%, METHYL SALICYLATE, 15%) | 0 | GEL | |||||||||
| 126628221 | 12662822 | 17 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | 50 MG, 2X/DAY | 0 | 50 | MG | TABLET | BID | |||||||
| 126628221 | 12662822 | 18 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, DAILY (MOUTH DAILY 30 MIN BEFORE BREAKFAST; STATUS: (TAKING) ) | 0 | 20 | MG | CAPSULE | |||||||
| 126628221 | 12662822 | 19 | C | ONDANSETRON HCL | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 4 MG, 3X/DAY (SIG: TK 1 T PO Q 8 H PRF NAUSEA) | 0 | 4 | MG | TABLET | TID | ||||||
| 126628221 | 12662822 | 20 | C | PREDNISOLONE ACETATE. | PREDNISOLONE ACETATE | 1 | ACETATE 1 % SUSPENSION; SIG: APPLY TO EYE. AS NEEDED | 0 | |||||||||||
| 126628221 | 12662822 | 21 | C | TRIAMCINOLONE ACETONIDE. | TRIAMCINOLONE ACETONIDE | 1 | UNK | 0 | OINTMENT | ||||||||||
| 126628221 | 12662822 | 22 | C | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 500 MG, UNK | 0 | 500 | MG | TABLET | |||||||
| 126628221 | 12662822 | 23 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 5 MG, DAILY | 0 | 5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126628221 | 12662822 | 1 | Myelodysplastic syndrome |
| 126628221 | 12662822 | 19 | Nausea |
| 126628221 | 12662822 | 21 | Rash pruritic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126628221 | 12662822 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126628221 | 12662822 | Arthralgia | |
| 126628221 | 12662822 | Back pain | |
| 126628221 | 12662822 | Conjunctival haemorrhage | |
| 126628221 | 12662822 | Contusion | |
| 126628221 | 12662822 | Disease progression | |
| 126628221 | 12662822 | Dry skin | |
| 126628221 | 12662822 | Ear pain | |
| 126628221 | 12662822 | Epistaxis | |
| 126628221 | 12662822 | Fatigue | |
| 126628221 | 12662822 | Glossodynia | |
| 126628221 | 12662822 | Haemorrhage | |
| 126628221 | 12662822 | Haemorrhoidal haemorrhage | |
| 126628221 | 12662822 | Musculoskeletal pain | |
| 126628221 | 12662822 | Myelodysplastic syndrome | |
| 126628221 | 12662822 | Neck pain | |
| 126628221 | 12662822 | Oral pain | |
| 126628221 | 12662822 | Rash erythematous |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126628221 | 12662822 | 1 | 20150921 | 0 |